Fuso Says Toray Jacked Up Damage Claim in Remitch Patent Suit

March 28, 2024
Fuso Pharmaceutical Industries said on March 27 that Toray Industries has excessively lifted its damage claims in their patent infringement lawsuit involving generic versions of the pruritus treatment Remitch OD Tablets (nalfurafine). In 2018, Toray took Fuso and Sawai Pharmaceutical...read more